1 unchanged sentence
Market Information
−Removed: The Company’s common stock, par value $0.10 per share, or Common Stock, trades on the New York Stock Exchange or NYSE under the symbol “LH”.
+Added: The Company’s common stock, par value $0.10 per share, or Common Stock, trades on the New York Stock Exchange under the symbol “LH”.
On February 23, 2026, there were approximately 1,032 holders of record of the Common Stock.
2 unchanged sentences
800-468-9716, website:
−Removed: www.https://equiniti.com/us/.
−Removed: The Company initiated a quarterly dividend beginning in the second quarter of 2022.
+Added: https://www.equiniti.com/us/.
The Company’s ability to pay dividends is primarily dependent on earnings from operations, the adequacy of capital and the availability of liquid assets for distribution.
3 unchanged sentences
Common Stock Performance
−Removed: The graph below shows the cumulative total return assuming an investment of $100 on December 31, 2019, in each of the Company’s Common Stock, the Standard & Poor’s, (S&P) 500 Index and the S&P 500 Health Care Index, and assuming that all dividends were reinvested.
+Added: The graph below shows the cumulative total return assuming an investment of $100 on December 31, 2020, in each of the Company’s Common Stock, the S&P 500 Index, and the S&P 500 Health Care Index, and assuming that all dividends were reinvested.
For the purpose of this graph, the distribution of 100% of the outstanding Common Stock of Fortrea to the Company’s shareholders, pursuant to which Fortrea became an independent company, is treated as a non-taxable cash dividend of $33.11 per share, an amount equal to the opening price of Fortrea common stock when it began trading on June 20, 2023, that was deemed reinvested in the Company’s Common Stock at the closing price on June 20, 2023.
−Removed: Comparison of Cumulative Total Return
12/2020 12/2021 12/2022 12/2023 12/2024 12/2025
3 unchanged sentences
S&P 500 Health Care Index $ 100.00 $ 126.13 $ 123.67 $ 126.21 $ 129.46 $ 148.36
−Removed: Issuer Purchases of Equity Securities (all amounts in millions, except per share amounts)
+Added: Issuer Purchases of Equity Securities (dollars and shares in millions, except per share amounts)
The following table sets forth information with respect to purchases of shares of the Company’s Common Stock made during the quarter ended December 31, 2025, by or on behalf of the Company:
5 unchanged sentences
During the year ended December 31, 2025, the Company purchased 1.8 shares of its Common Stock at an average price per share of $254.17 for a total cost of $450.0.
−Removed: When the Company repurchases shares, the amount paid to repurchase the shares in excess of the par or stated value is allocated to additional paid-in-capital unless subject to limitation or the balance in additional paid-in-capital is exhausted.
−Removed: Remaining amounts are recognized as a reduction in retained earnings.
−Removed: At the end of 2024, the Company had outstanding authorization from its Board to purchase up to $1,280.4 maximum value of the Company’s Common Stock.
+Added: At December 31, 2025, the Company had outstanding authorization from its Board to purchase up to $830.4 maximum value of the Company’s Common Stock.
The repurchase authorization has no expiration date.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.